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ABSTRACT
The influenza A virus genome consists of eight segments of negative-sense RNA that encode up to 18 proteins. 
During the process of viral replication, positive-sense (+)RNA (cRNA) or messenger RNA (mRNA) is synthesized. To-
day, there is only a partial understanding of the function of several secondary structures within vRNA and cRNA pro-
moters, and splice sites in the M and NS genes. The most precise secondary structure of (+)RNA has been determined 
for the NS segment of influenza A virus. 
The influenza A virus NS gene features two regions with a conserved mRNA secondary structure located near 
splice sites. Here, we compared 4 variants of the A/Puerto Rico/8/1934 strain featuring different combinations of sec-
ondary structures at the NS segment (+)RNA regions 82-148 and 497-564. We found that RNA structures did not affect 
viral replication in cell culture. However, one of the viruses demonstrated lower NS1 and NEP expression levels during 
early stage cell infection as well as reduced pathogenicity in mice compared to other variants. In particular, this virus 
is characterized by an RNA hairpin in the 82-148 region and a stable hairpin in the 497-564 region.
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INTRODUCTION
It is well known that RNA secondary structures are vitally 
important for the life cycle of many DNA and RNA con-
taining viruses. RNA hairpins are required for viral rep-
lication, mRNA editing, microRNA biogenesis, splicing, 
genome packaging, etc. [1, 2]. Internal ribosome entry 
sites (IRES), consisting of extensive regions of structured 
RNA, are key elements for the initiation of cap-indepen-
dent translation and have been found in many patho-
genic viruses [3–6]. RNA secondary structures of Rous 
sarcoma virus, retroviruses, coronaviruses, and many 
other viruses are responsible for switching between the 
expression of overlapping reading frames, which ex-
pand the information capacity of the viral genome [7, 8]. 
Hairpin-type secondary structures of flavivirus genomes 
provide the translation of full-length capsid protein in 
the presence of multiple start codons and are required 
for viral replication [9]. Conserved corkscrew structures 
in terminal regions have been found in various groups of 
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negative-sense RNA viruses, including influenza, and are 
involved in various steps of viral replication [10]. 
The influenza A virus (IAV) genome consists of eight 
segments of negative-sense RNA that encode up to 
18 proteins [11]. During the process of viral replication, 
positive-sense RNA is also synthesized, which is clas-
sified into a genomic complementary (+)RNA (cRNA) 
or messenger RNA (mRNA). Currently, the function of 
several secondary structures within promoter regions of 
vRNA and cRNA, and splice sites in the M and NS genes 
[12] are only partially understood. 
The most precise secondary structure of (+)RNA has 
been determined for the NS segment of influenza A vi-
rus [13–17]. This genomic segment encodes at least two 
important non-structural proteins (NS and NEP), and 
contains a splicing regulated switch between the corre-
sponding open reading frames (ORFs). The multifunc-
tional NS1 protein is involved in the inhibition of the 
cellular immune response during viral infection [18]. 
NS1 expression varies among IAV strains. For example, 
A/Brevig Mission/1/1918 (H1N1), responsible for the 
largest pandemic in human history, and considered the 
ancestor of all modern human IAV strains, has a high lev-
el of NS1 expression compared to less pathogenic strains 
[19]. The main function of the NEP protein is related to 
the nuclear export of viral ribonucleoproteins [20]. The 
optimal expression of NEP protein contributes to the 
maintenance of effective viral replication [21–23].
Regions with a conserved secondary structure, cor-
responding to NS (+)RNA position 82-148 and position 
497-564, are localized close to the 5’ and 3’ splice sites. 
The first region is located within the NS1 ORF; the sec-
ond region is located within NS1 and NEP ORFs [24]. Ac-
cording to previously published data, both NS (+)RNA re-
gions fold into several alternative secondary structures: 
region 82-148 forms hairpin or multi-branch structures 
[15–17]; region 497-564 is characterized by the forma-
tion of two structures with similar energies (pseudoknot 
or hairpin) [14].
It is noteworthy that NS (+)RNA secondary structures 
differ among IAV strains [14, 24, 25]. The highly virulent 
A/Brevig Mission/1/1918 (H1N1) strain has stable RNA 
hairpin structures in both of the aforementioned (NS 
RNA) regions. Highly virulent avian influenza A (H5N1) 
strains that appeared after 2001 carry more stable 
RNA hairpins in the second region compared to previ-
ous strains [14]. Since the NS gene is closely associated 
with host adaptation, structural motifs may affect host 
specificity or viral pathogenicity through the regulation 
of NS1 expression [15, 26]. However, the role of the ob-
served hairpins is yet to be determined. 
Here, we present the study results of 4  previously 
constructed viruses based on the A/Puerto Rico/8/1934 
(H1N1) strain, featuring different combinations of sec-
ondary structures in the NS mRNA region 82-148 and 
region 497-564 [26]. The NS gene sequences, providing 
stable RNA hairpins in the corresponding regions, were 
adopted from the aforementioned influenza strains, 
while the sequences with no stable secondary struc-
tures were taken from their closest “counterparts” with 
a minimum number of mismatches (Fig. 1). RNA second-
ary structure analysis was performed using the RNAfold 
online tool and did not include a pseudoknot structure 
prediction [27]. The difference in the NS region 82-148 
mRNA structure was concurrent with 2 synonymous mu-
tations (G123A, A132G). The difference in the NS region 
497-564 mRNA structure was concurrent with one non-
synonymous substitution in the NS1 open reading frame 
(G166N) and two non-synonymous substitutions in the 
NEP ORF (M14V, G22A). Virus variants bearing different 
secondary structure combinations were named according 
to the presence (1) or absence (0) of an RNA hairpin in 
the NS region 82-148 and/or region 497-564. The vari-
ants were named as: V1-1, V1-0, V0-1, or V0-0.
MATERIALS AND METHODS
Viruses
Four virus variants with different combinations of sec-
ondary structures in the two NS RNA regions (82-148 
and 497-564) were previously obtained by reverse genet-
ics, followed by the virus production in Vero cells [26]. All 
four variants are based on the laboratory strain A/Puerto 
Rico/8/1934 (H1N1).
Cell culture
Madin-Darby Canine Kidney (MDCK) London line cells 
(International Reagent Resource, #FR-58) were grown in 
AlphaMEM medium (BioloT, Russia) supplemented with 
2 mM L-glutamine and 10% SC-biol FBS (BioloT, Russia). 
A549 cells (ATCC, #CCL-185) were cultivated in DMEM/
F12 media (Gibco) supplemented with 2% GlutaMAX 
(Gibco) and 10% FBS (Gibco). The Vero cell line (ATCC, 
#CCL-81) was previously adapted to an OptiPro serum-
free medium (Gibco) supplemented with 2% GlutaMAX 
(Gibco). Primary chicken kidney cells culture (CK, kindly 
provided by K. A. Vasiliev, Laboratory of Vector Vaccines, 
Smorodintsev Research Institute of Influenza) were 
grown in a DMEM/F12 media (Gibco) supplemented with 
1% GlutaMAX (Gibco), 1% sodium pyruvate (Gibco), and 
10% SC-biol FBS (BioloT, Russia).
Viral infectious activity
Infectious activity of virus samples was measured by ti-
tration in cells (overnight confluent, 96-well plate for-
mat) using serum-free culture media (described above) 
supplemented with 1% antibiotic-antimycotic (Gibco) 
and TPCK-trypsin (Sigma). Trypsin concentrations were: 
2.5  μg/ml for MDCK; 0.5  μg/ml for A549; and 0.5  μg/
ml for Vero cells. Titration in primary CK cells was per-
formed without trypsin. Titration in 10-day old embryo-
nated chicken eggs was conducted by the inoculation of 
the allantoic cavity with 200 μl of 10-fold diluted virus 
sample in PBS supplemented with 1% antibiotic-anti-
mycotic (Gibco). The 50% Tissue Culture Infectious Dose 
(TCID50) and the 50% Embryonic Infectious Dose (EID50) 
were calculated according to the Reed and Muench meth-
od [28] following the hemagglutination assay (HA) per-
formed with 0.75% suspension of chicken red blood cells. 
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Viral infectious activity was expressed as log10TCID50/ml 
or log10EID50/ml.
Western blotting
A549 cells (overnight confluent monolayer, 12-well plate 
format, in triplicate) were infected with each virus at a 
multiplicity of infection (moi) of 1 TCID50/cell. After 1 h 
of virus adsorption at 37℃, inoculum was replaced with 
serum-free medium. After 9-12 h of incubation, the me-
dium was removed. Cells were then scraped, washed once, 
and resuspended in 100 μl PBS. Sample protein concen-
trations were measured using the DC Protein Assay Kit I 
(Bio-Rad, #5000111) in triplicates. Then, samples (0.5 μg 
or 15  μg of total protein for NS1 or NEP detection, re-
spectively) were mixed with 1X Laemmli Sample Buffer 
(Bio-Rad) containing β-mercaptoethanol and incubated 
for 5 min. at 100°C. The samples were  separated by SDS 
PAGE using Mini-PROTEAN TGX Stain-Free Precast Pro-
tein Gels (Bio-Rad, #4568121) following the manufactur-
er’s instructions.
After separation, proteins were transferred onto ni-
trocellulose membranes using the Trans-Blot Turbo Mini 
(Bio-Rad, #1704156). Membranes were blocked overnight 
at 4℃ in 5% low fat milk (Bio-Rad) in PBST (PBS with 
0.1% tween-20), followed by 1 h of incubation with pri-
mary antibody at room temperature. We used the fol-
lowing antibodies (1  μg/ml in blocking buffer): mouse 
monoclonal antibody 1H7 against NS1 [29]; rabbit mono-
clonal antibody against NEP (Novus Biologicals #NBP2-
42872); and mouse monoclonal antibody against alpha-
tubulin (Sigma-Aldrich #T6074). The membranes were 
washed twice in PBST and incubated with GAM-HRP 
(Bio-Rad, #1706515) or GAR-HRP (Bio-Rad #1721011) 
secondary antibodies (1 μg/ml in blocking buffer) for 1 h 
at room temperature. After two washes with PBST, the 
membranes were incubated with the Clarity Western ECL 
Substrate kit (Bio-Rad) and analyzed with the ChemiDoc 
System (Bio-Rad). The ImageLab 4.1 (Bio-Rad) and Im-
ageJ 1.38 [30] programs were used for the quantitative 
analysis.
Laboratory animal infection
Female BALB/c mice (18–20 g, aged 6-8 weeks) were pur-
chased from the Stolbovaya Biomedical Scientific Center 
FMBA (Russia). Animal care and all of the experiments 
were performed according to international guidelines 
[31]. Animals were randomly divided into four groups and 
intranasally infected with viruses diluted in DPBS (Bio-
lot, Russia) (30  μl/mouse) under mild ether anesthesia. 
After infection, animals were monitored daily, including 
the weighing and assessment of mortality. The testing 
for the presence of virus-specific antibodies in the blood 
sera of surviving mice was performed on day 21 after in-
fection using the standard hemagglutination inhibition 
Fig. 1. Conserved RNA secondary structures of the NS gene (+) RNA. Region 82-148 folds into a hairpin (1) in A/Brevig Mission/1/1918 
(H1N1) virus NS (+)RNA (E = -23.9 kcal/mol) and does not (0) in mutated sequence featuring G123A and A132G substitutions (E = -21.6 kcal/
mol). Region 497-564 folds into a hairpin (1) in A/Vietnam/1194/2004 (H5N1) strain NS (+)RNA (E = -27.5 kcal/mol) and does not (0) in 
mutated sequence featuring G511A, G512A, and C537G substitutions (E = -20.9 kcal/mol). RNA secondary structures were predicted using 
the RNAfold online tool [27].
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(HI) assay. The calculation of the 50% mouse lethal dose 
(MLD50) and 50% mouse infectious dose (MID50) were per-
formed according to the Reed and Muench method [28].
In order to estimate the viral replication in animal 
lungs, the mice were infected with 10 MID50 of each virus. 
Four mice from each group were euthanized at specific 
time points (2, 4, and 6 days post infection (pi)). The lungs 
were isolated, and 10% tissue suspensions were prepared 
in DPBS (Biolot, Russia) with 1% antibiotic-antimycotic 
(Gibco). After centrifugation (3000 rpm, 10 min), suspen-
sions were used to determine the presence of infectious 
viral particles by titration in MDCK cell culture.
Statistics
Statistical data analysis was performed using Microsoft 
Excel 2007 and GraphPad Prism 6.01. Two-way ANOVA 
with Tukey’s or Sidak’s post-test was used to assess the 
significance of any differences between viruses at spe-
cific time points. The significance threshold was set at 
p<0.05. The data are presented as mean ± standard de-
viation (M±SD).
RESULTS
Infectious activity of viruses in different living 
systems
Four influenza viruses (V1-1, V1-0, V0-1, V0-0), based on the 
A/Puerto Rico/8/34 strain and with different combina-
tions of NS (+)RNA secondary structure in the region 
82-148 and region 497-564, were previously constructed 
[26]. We first compared the infectious activity of the vi-
ruses in Vero, MDCK, A549, and CK cells and in 10-day old 
embryonated chicken eggs. The results shown in Table 1 
indicate that there were no statistically significant dif-
ferences between the viruses, indicating equal amounts 
of infectious viral particles in each sample.
Table 1. Infectious activity of viruses featuring different NS RNA 
structures in different cells
Cells Infectious activity
(log10TCID50/ml or log10EID50/ml)
V1-1 V1-0 V0-1 V0-0
A549 7.4±0.55 7.78±0.69 7.94±0.59 7.91±0.64
MDCK 9.44±0.10 9.89±0.18 9.17±0.29 9.19±0.50
Vero 8.78±0.19 8.56±0.10 8.72±0.25 8.81±0.34
CK 7.55±0.11 7.95±0.48 7.56±0.10 7.56±0.10
CE 9.89±0.97 9.47±0.42 9.22±0.29 9.53±0.29
Data are presented as M±SD (n=3)
First cycle viral growth kinetics in vitro
In previous research, we evaluated the replication ability 
of viruses by multi-cycle growth curves in Vero, MDCK, 
or A549 cells [26]. We did not observe any significant dif-
ferences in multi-cycle cell infection. However, the vi-
ruses differed from each other in infectious activity 48h 
post transfection. This suggests that the aforementioned 
RNA structures may be important in the early stages of 
infection [26]. Over the course of this project, we stud-
ied the replication properties of the viruses with differ-
ent NS mRNA secondary structures during the first viral 
cycle (Fig. 2).
A549, MDCK, and Vero cells were infected with each 
virus at a MOI of 0.1 or 1.0  (TCID50/cell) in triplicates 
(overnight confluent, 6-well plate format). At 3, 6, 9, and 
12 hours pi (hpi), viral progeny was collected from the su-
pernatants, and infectious titers were measured in MDCK 
cells. According to the obtained results, no differences 
were found between the strains. Therefore, there was no 
correlation between viral replication in cell culture and 
the types of NS (+)RNA secondary structure present.
Viral protein production levels in infected cells
In order to estimate how the RNA structure affects viral 
protein expression, the content of NEP and NS1 proteins 
in infected A549 whole cell lysate was measured by West-
ern blot  at 9 and 12 hpi, respectively (Fig. 3). The relative 
expression levels were determined by measuring the in-
tensities of the obtained bands with subsequent normal-
ization to that of α-tubulin. It was found that NEP levels in 
the cells infected with V0-0 were higher than those of other 
samples. The lowest NEP production corresponded to V0-1. 
Viruses V1-1 and V1-0 had comparable levels of NEP (Fig. 3A).
Western blot also confirmed that the hairpin in the NS 
(+)RNA region 82-148 enhanced NS1 expression during 
early infection in A549 cells (Fig. 3B). According to mea-
surements, the production level of NS1 in cells infected 
with V1-1 or V1-0 was approximately twice higher than that 
seen in V0-1 or V0-0 infected cells which is entirely consistent 
with previously published results obtained by ELISA [26].
Therefore, NS (+)RNA secondary structures were found 
to affect the production of viral proteins in infected cells. 
Despite the fact that NS (+)RNA secondary structures did 
not affect viral replication in vitro, the study was contin-
ued using an in vivo model. This approach was followed 
because active NS1 protein synthesis in the first hours of 
infection may inhibit the interferon (IFN) dependent im-
mune response and thereby affect disease severity.
Viral reproduction in infected mice
There were no statistically significant differences be-
tween the four viral variants in terms of MID50 and MLD50. 
The standard deviations of MLD50 and MID50 were within 
+/- 0.5 log10TCID50, which is within the error of the titra-
tion method (Table 2). To study the dynamics of the (vi-
ral) infectious process, animals were infected with each 
virus at a dose of 10 MID50 per mouse. They were moni-
tored daily, and the presence of virus in the lungs was de-
termined at 2, 4, and 6 days pi. According to the data, V0-1 
was less pathogenic for mice. Mice infected with V0-1 had 
a tendency to lose weight more slowly compared to other 
animals (Fig. 4A). On the 2nd day, a difference between 
V1-1 and V0-1 viruses was observed. On the 6th day after 
infection, a decrease in lung infectious titer of V0-1 was 
seen (Fig. 4B). This proves that a specific combination of 
NS (+)RNA secondary structures affects viral pathogenic-
ity in mice.
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Fig. 2. Growth curves of viruses featuring different NS RNA structures.
A549 (A, B), MDCK (C, D), and Vero (E, F) cells were infected at a moi of 0.1 or 1 TCID50/cell. Infectious activity of viral progeny was mea-
sured at the indicated time points by TCID50 assay. Data are presented as M ± SD (n=3).
DISCUSSION
Previously published experiments devoted to NS gene 
secondary structures were performed only in cell culture 
[32] or in vitro [15] without taking into account the possi-
ble contributions of the structural combinations. In this 
study, we have shown that certain NS (+)RNA secondary 
structure combinations regulate NS1 and NEP produc-
tion in vitro and can affect the level of viral pathogenicity 
in vivo. 
Here we have demonstrated, for the first time, that a 
specific combination (presence of a hairpin at position 
Table  2. Calculated MID50 and MLD50 values of viruses featuring 
different NS RNA structures
Virus 1 MLD50  
(log10TCID50/ml)






Data are presented as (M ± SD) for two independent experiments.
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497-564 and absence of a hairpin structure at position 
82-148) leads to decreased NEP expression in infected 
A549 cells (V0-1 compared to V0-0) (Fig. 3A). 
If RNA hairpin was present in 82-148 region, there 
was no effect of RNA secondary structure in the second 
region (497-564) on the NEP expression. The V1-1 and 
V1-0 variants displayed similar NEP expression levels 
(Fig.3).
Despite the fact that the region 497-564 falls in the 
NS1 ORF, the hairpin status there did not affect NS1 pro-
tein expression, regardless of the region 82-148 struc-
tural status. This is best seen in Fig.3B when comparing: 
V0-1 with V0-0; and V1-1 with V1-0. 
In contrast, the region 82-148 RNA hairpin drasti-
cally increased NS1 expression, regardless of the region 
497-564 structural status (comparison of V1-1 with V0-1; 
V1-0 with V0-0). Variations in the NS1 expression level were 
previously demonstrated by ELISA [26] and additionally 
confirmed in this study using Western blot. Viral con-
struct V1-0 (bearing a single RNA hairpin structure, from 
the A/Brevig Mission/1/1918 (H1N1) strain, in the region 
82-148 of NS (+)RNA) was characterized by higher NS1 
expression and lower NEP expression in infected A549 
cells relative to a V0-0, which bears no hairpin in either 
region (Fig.  3). Since region 82-148 is only included in 
the NS1 ORF, the negative effect on NEP production 
probably occurs indirectly.
NS1 mRNA and NEP mRNA share the first 56 nucleo-
tides including the untranslated region (5′-UTR) and first 
30 nucleotides of the coding sequence. However, the NS1 
mRNA in V1- 0 bears hairpin 82-148, presumably provid-
ing a more efficient ribosome-NS1 mRNA interaction, 
leading to high NS1 expression. This may lead to a lack 
of ribosome availability for NEP mRNA, which is approxi-
mately tenfold less present in infected cells compared to 
the unspliced NS mRNA form [33,34]. Therefore, we ob-
served a negative influence of this structure on NEP ex-
pression and the suppression of region 497-564 structur-
al effects on NEP translation. However, the mechanisms 
by which these secondary structure combinations affect 
NEP expression require further clarification.
Earlier, the stabilization of the RNA structure in the 
region 497-564 was demonstrated to change NS mRNA 
splicing in cell culture [32]. However, we did not observe 
the aforementioned difference between strains in our 
previous study measuring NS1 and NEP mRNA levels [26]. 
Therefore, we assume that NS (+)RNA secondary struc-
tures have effects at the level of translation: the hairpin 
Fig. 3. NS1 and NEP expression in A549 cells infected with viruses featuring different NS RNA structures. Cell cultures were infected with 
each virus at a moi of 1 TCID50/cell (n=3). NEP (A) and NS1 (B) proteins were analyzed by Western blot at 9 and 12 hpi, respectively.
Fig. 4. Pathogenicity of viruses featuring different NS RNA structures for mice.
Mice were infected with 10 MID50 of each virus. (A) The dynamics of the weight of infected animals measured individually and presented as 
mean % of initial weight of the group; (B) Viral replication in lungs of infected mice. The viral infectious activity was measured by TCID50 
assay of 10% lung suspensions. Individual values are presented. Sign (*) indicates the significant differences between V1-1 and V0-1 on day 2, 
p<0.05; significant differences between V0-1 and other viruses on day 6, p<0.05 (two-way ANOVA with Sidak’s multiple comparisons test).
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in the region 82-148 enhances NS1 production, while the 
hairpin in region 497-564 inhibits NEP expression.
Our current in vivo viral replication experiment 
showed differences between the strains, depending on 
NS (+)RNA secondary structure combinations. Animals 
infected with V0-1 (without a hairpin in region 82-148 and 
a stable hairpin in region 497-564) contained less viral 
load in the lungs compared to animals infected with the 
other virus variants. This suggests that V0-1 is less patho-
genic than the other strains. We assume that the absence 
of an RNA hairpin in the region 82-148 causes decreased 
NS1 protein expression, leading to a reduced ability of 
V0-1 to resist the IFN dependent immune response com-
pared to the V1-1. The presence of an RNA hairpin in the 
region 497-564 results in decreased NEP protein expres-
sion, which apparently can also cause the mild attenua-
tion of V0-1 in laboratory animals. The NEP protein con-
trols the optimal speed of the viral cycle and, therefore, 
its decreased expression can negatively affect the viral 
replication process [35].
It should be mentioned that the different RNA sec-
ondary structures (between the A/Puerto Rico/8/1934-
derived virus variants used in this study) were obtained 
by introducing mutations into the aforementioned RNA 
regions. The mutations (G511A, G512A, C537G) respon-
sible for the secondary structure changes in the RNA re-
gion 497-564 cause one amino acid substitution in NS1 
(N166G) and two substitutions in NEP (V14M and A22G). 
Amino acid position 166 is located in the proline-rich 
162-170 loop of NS1 and is not included in the known 
structural or functional domains of the NS1 protein [36]. 
Therefore, we think it is unlikely that this substitution 
significantly contributes to the observed differences be-
tween virus variants, although this cannot be ruled out.
The NEP amino acid substitutions are located in the 
mobile, unstructured region of the N-terminal domain, 
the flexibility of which may be important for interaction 
with cellular proteins during nuclear export of viral RNA 
[37]. The aforementioned amino acids (valine/methio-
nine at position 14, glycine/alanine at position 22) do not 
differ by hydrophobicity or charge. NEP amino acid resi-
due 14 belongs to the 12-21 nuclear export signal, while 
position 22 does not affect any functional sequences. 
Therefore, V14M amino acid substitution may influence 
the viral RNA export process, leading to viral protein ex-
pression differences between pairs of viruses (V1-1 and 
V1-0; V0-  1 and V0-0). Since we did not observe the effect 
of the indicated mutations on the NS1 or NP expression 
in cell culture (results not shown), we suggest that their 
impact on the viral RNA export process is not significant. 
Nevertheless, the contribution of non-synonymous mu-
tations to the observed phenotypes cannot be completely 
excluded from consideration. 
It is important to note that our data contradicts an 
earlier hypothesis asserting that a hairpin in the region 
497-564, typically found in highly virulent H5N1 strains, 
may act as an additional pathogenicity factor [14]. The 
formation of a stable RNA hairpin in such viruses may be 
host-specific, associated with higher body temperatures 
in birds, or an additional secondary structure stabiliza-
tion requirement (compared to human strains) [13, 38].
Overall, we have demonstrated that NS mRNA sec-
ondary structures can affect viral replication in vivo. 
Previously, it was pointed out that regions of viral RNA 
featuring conserved secondary structures may be used as 
potential targets in new generations of antiviral therapy 
[12, 39] or for the development of live vaccines [32]. How-
ever, considering the slight contribution of NS mRNA 
secondary structures to viral pathogenesis, these struc-
tures are unlikely to be significant pathogenicity factors, 
but are rather involved in the fine regulations of NS1 and 
NEP gene expression.
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